vs

Side-by-side financial comparison of Dexcom (DXCM) and F&G Annuities & Life, Inc. (FG). Click either name above to swap in a different company.

F&G Annuities & Life, Inc. is the larger business by last-quarter revenue ($1.8B vs $1.3B, roughly 1.4× Dexcom). Dexcom runs the higher net margin — 21.2% vs 7.3%, a 14.0% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 13.2%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 6.1%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

F&G Annuities & Life, Inc. is a public company headquartered in Des Moines, Iowa. It primarily provides annuities, life insurance, and pension buyout services. The company was founded in 1959.

DXCM vs FG — Head-to-Head

Bigger by revenue
FG
FG
1.4× larger
FG
$1.8B
$1.3B
DXCM
Growing faster (revenue YoY)
DXCM
DXCM
+8.4% gap
DXCM
21.6%
13.2%
FG
Higher net margin
DXCM
DXCM
14.0% more per $
DXCM
21.2%
7.3%
FG
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
6.1%
FG

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DXCM
DXCM
FG
FG
Revenue
$1.3B
$1.8B
Net Profit
$267.3M
$128.0M
Gross Margin
62.9%
Operating Margin
25.6%
Net Margin
21.2%
7.3%
Revenue YoY
21.6%
13.2%
Net Profit YoY
153.6%
-60.9%
EPS (diluted)
$0.67
$0.97

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
FG
FG
Q1 26
$1.3B
Q4 25
$1.3B
$1.8B
Q3 25
$1.2B
$1.7B
Q2 25
$1.2B
$1.4B
Q1 25
$1.0B
$908.0M
Q4 24
$1.1B
$1.6B
Q3 24
$994.2M
$1.4B
Q2 24
$1.0B
$1.2B
Net Profit
DXCM
DXCM
FG
FG
Q1 26
$267.3M
Q4 25
$267.3M
$128.0M
Q3 25
$283.8M
$118.0M
Q2 25
$179.8M
$40.0M
Q1 25
$105.4M
$-21.0M
Q4 24
$151.7M
$327.0M
Q3 24
$134.6M
$-6.0M
Q2 24
$143.5M
$203.0M
Gross Margin
DXCM
DXCM
FG
FG
Q1 26
62.9%
Q4 25
62.9%
Q3 25
60.5%
Q2 25
59.5%
Q1 25
56.9%
Q4 24
58.9%
Q3 24
59.7%
Q2 24
62.4%
Operating Margin
DXCM
DXCM
FG
FG
Q1 26
25.6%
Q4 25
25.6%
Q3 25
20.1%
Q2 25
18.4%
Q1 25
12.9%
Q4 24
17.0%
Q3 24
15.3%
Q2 24
15.7%
Net Margin
DXCM
DXCM
FG
FG
Q1 26
21.2%
Q4 25
21.2%
7.3%
Q3 25
23.5%
7.0%
Q2 25
15.5%
2.9%
Q1 25
10.2%
-2.3%
Q4 24
13.6%
21.0%
Q3 24
13.5%
-0.4%
Q2 24
14.3%
17.3%
EPS (diluted)
DXCM
DXCM
FG
FG
Q1 26
$0.67
Q4 25
$0.67
$0.97
Q3 25
$0.70
$0.85
Q2 25
$0.45
$0.26
Q1 25
$0.27
$-0.20
Q4 24
$0.37
$2.53
Q3 24
$0.34
$-0.08
Q2 24
$0.35
$1.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
FG
FG
Cash + ST InvestmentsLiquidity on hand
$917.7M
$1.5B
Total DebtLower is stronger
$2.2B
Stockholders' EquityBook value
$2.7B
$4.8B
Total Assets
$6.3B
$98.4B
Debt / EquityLower = less leverage
0.47×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
FG
FG
Q1 26
$917.7M
Q4 25
$917.7M
$1.5B
Q3 25
$1.8B
$2.2B
Q2 25
$1.2B
$1.9B
Q1 25
$904.9M
$3.3B
Q4 24
$606.1M
$2.3B
Q3 24
$621.2M
$3.5B
Q2 24
$939.2M
$3.5B
Total Debt
DXCM
DXCM
FG
FG
Q1 26
Q4 25
$2.2B
Q3 25
$2.2B
Q2 25
$2.2B
Q1 25
$2.2B
Q4 24
$2.2B
Q3 24
$2.0B
Q2 24
$2.0B
Stockholders' Equity
DXCM
DXCM
FG
FG
Q1 26
$2.7B
Q4 25
$2.7B
$4.8B
Q3 25
$2.7B
$4.8B
Q2 25
$2.6B
$4.4B
Q1 25
$2.3B
$4.4B
Q4 24
$2.1B
$4.0B
Q3 24
$2.0B
$4.3B
Q2 24
$2.4B
$3.7B
Total Assets
DXCM
DXCM
FG
FG
Q1 26
$6.3B
Q4 25
$6.3B
$98.4B
Q3 25
$7.5B
$96.1B
Q2 25
$7.3B
$91.8B
Q1 25
$6.8B
$88.0B
Q4 24
$6.5B
$85.0B
Q3 24
$6.4B
$84.1B
Q2 24
$6.8B
$78.5B
Debt / Equity
DXCM
DXCM
FG
FG
Q1 26
Q4 25
0.47×
Q3 25
0.46×
Q2 25
0.50×
Q1 25
0.51×
Q4 24
0.55×
Q3 24
0.47×
Q2 24
0.56×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
FG
FG
Operating Cash FlowLast quarter
$1.2B
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
9.13×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
FG
FG
Q1 26
Q4 25
$294.0M
$1.2B
Q3 25
$659.9M
$937.0M
Q2 25
$303.0M
$1.6B
Q1 25
$183.8M
$956.0M
Q4 24
$301.4M
$1.3B
Q3 24
$199.5M
$2.1B
Q2 24
$279.4M
$1.1B
Free Cash Flow
DXCM
DXCM
FG
FG
Q1 26
Q4 25
$192.1M
Q3 25
$579.4M
Q2 25
$208.9M
Q1 25
$96.8M
Q4 24
$176.8M
Q3 24
$88.3M
Q2 24
$213.3M
FCF Margin
DXCM
DXCM
FG
FG
Q1 26
Q4 25
15.3%
Q3 25
47.9%
Q2 25
18.1%
Q1 25
9.3%
Q4 24
15.9%
Q3 24
8.9%
Q2 24
21.2%
Capex Intensity
DXCM
DXCM
FG
FG
Q1 26
Q4 25
8.1%
Q3 25
6.7%
Q2 25
8.1%
Q1 25
8.4%
Q4 24
11.2%
Q3 24
11.2%
Q2 24
6.6%
Cash Conversion
DXCM
DXCM
FG
FG
Q1 26
Q4 25
1.10×
9.13×
Q3 25
2.33×
7.94×
Q2 25
1.69×
40.50×
Q1 25
1.74×
Q4 24
1.99×
4.04×
Q3 24
1.48×
Q2 24
1.95×
5.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons